A new study published on the preprint server medRxiv* in May 2020 reports a model that could help evolve appropriate dosage protocols for future clinical trials of the repurposed drug nitazoxanide in ...
During the coronavirus disease 2019 (COVID-19) pandemic, there have been many instances of drugs being repurposed for use against the disease. These include trialed and approved drugs such as ...
(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia. Nikhil Lalwani, President ...
PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...
Please provide your email address to receive an email when new articles are posted on . Adding nitazoxanide to standard of care for the treatment of children and adults with severe acute respiratory ...